Neurogene Stock Price History

NGNE Stock   16.70  0.10  0.60%   
Below is the normalized historical share price chart for Neurogene extending back to March 07, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurogene stands at 16.70, as last reported on the 17th of March 2025, with the highest price reaching 17.24 and the lowest price hitting 16.46 during the day.
IPO Date
7th of March 2014
200 Day MA
38.9992
50 Day MA
46.9117
 
Yuan Drop
 
Covid
If you're considering investing in Neurogene Stock, it is important to understand the factors that can impact its price. Neurogene has Sharpe Ratio of -0.0949, which conveys that the firm had a -0.0949 % return per unit of risk over the last 3 months. Neurogene exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neurogene's Standard Deviation of 4.89, mean deviation of 3.62, and Risk Adjusted Performance of (0.07) to check out the risk estimate we provide.
  
The current year's Total Stockholder Equity is expected to grow to about 175.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 14 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.19, whereas Price To Sales Ratio is forecasted to decline to 32.51. Neurogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0949

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNGNE

Estimated Market Risk

 4.91
  actual daily
43
57% of assets are more volatile

Expected Return

 -0.47
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Neurogene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurogene by adding Neurogene to a well-diversified portfolio.
Price Book
1.801
Enterprise Value Ebitda
(8.02)
Price Sales
268.1876
Shares Float
4.1 M
Wall Street Target Price
54.6

Neurogene Stock Price History Chart

There are several ways to analyze Neurogene Stock price data. The simplest method is using a basic Neurogene candlestick price chart, which shows Neurogene price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 16, 202425.13
Lowest PriceJanuary 24, 202515.06

Neurogene March 17, 2025 Stock Price Synopsis

Various analyses of Neurogene's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurogene Stock. It can be used to describe the percentage change in the price of Neurogene from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurogene Stock.
Neurogene Price Action Indicator(0.20)
Neurogene Price Daily Balance Of Power(0.13)
Neurogene Price Rate Of Daily Change 0.99 

Neurogene March 17, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Neurogene Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Neurogene intraday prices and daily technical indicators to check the level of noise trading in Neurogene Stock and then apply it to test your longer-term investment strategies against Neurogene.

Neurogene Stock Price History Data

The price series of Neurogene for the period between Tue, Dec 17, 2024 and Mon, Mar 17, 2025 has a statistical range of 10.07 with a coefficient of variation of 15.5. The daily prices for the period are spread out with arithmetic mean of 19.26. The median price for the last 90 days is 18.08. The company underwent 1:4 stock split on 19th of December 2023.
OpenHighLowCloseVolume
03/17/2025
 17.13  17.24  16.46  16.70 
03/14/2025 17.13  17.24  16.46  16.70  221,389 
03/13/2025 17.85  17.89  16.36  16.80  147,380 
03/12/2025 18.12  18.62  17.45  17.78  119,358 
03/11/2025 17.06  17.93  16.76  17.67  217,546 
03/10/2025 17.02  17.40  16.65  17.05  127,281 
03/07/2025 16.80  17.48  16.44  17.28  76,721 
03/06/2025 16.61  16.99  16.24  16.75  649,953 
03/05/2025 16.10  17.31  16.08  16.91  88,912 
03/04/2025 16.03  16.51  15.69  16.35  144,890 
03/03/2025 17.78  17.78  16.20  16.21  170,058 
02/28/2025 17.18  17.77  16.54  17.69  59,465 
02/27/2025 17.20  17.70  16.73  17.10  202,599 
02/26/2025 16.80  17.31  16.65  17.20  126,883 
02/25/2025 16.45  16.93  16.04  16.76  205,083 
02/24/2025 16.75  17.54  16.52  16.60  182,626 
02/21/2025 17.53  17.91  16.95  17.36  137,367 
02/20/2025 16.89  17.55  16.72  17.31  120,236 
02/19/2025 17.07  17.80  16.96  16.97  242,710 
02/18/2025 18.42  19.35  16.95  17.35  141,355 
02/14/2025 18.75  19.97  18.09  18.42  102,861 
02/13/2025 18.65  19.48  18.24  18.77  133,081 
02/12/2025 17.31  18.61  17.31  18.57  100,263 
02/11/2025 18.33  18.90  17.17  17.79  157,016 
02/10/2025 20.77  20.95  17.73  18.89  301,383 
02/07/2025 23.06  23.70  19.82  20.46  314,540 
02/06/2025 21.51  26.48  20.96  23.30  1,018,893 
02/05/2025 18.07  23.73  17.64  21.53  816,739 
02/04/2025 16.88  18.33  16.88  18.08  173,370 
02/03/2025 15.25  17.28  15.16  16.84  211,246 
01/31/2025 15.57  16.33  15.21  15.85  329,047 
01/30/2025 15.53  16.70  15.51  15.53  219,345 
01/29/2025 15.41  15.88  15.25  15.51  137,543 
01/28/2025 15.00  15.62  14.54  15.48  186,768 
01/27/2025 14.82  16.29  14.78  15.08  241,953 
01/24/2025 15.45  15.63  14.42  15.06  472,026 
01/23/2025 15.86  16.12  15.33  15.58  267,446 
01/22/2025 16.31  16.85  15.92  15.95  135,647 
01/21/2025 16.69  16.98  16.00  16.62  202,068 
01/17/2025 17.60  17.75  16.14  16.60  159,375 
01/16/2025 18.43  18.48  17.50  17.63  149,520 
01/15/2025 18.59  19.14  18.15  18.54  85,442 
01/14/2025 19.07  20.29  17.63  17.89  282,899 
01/13/2025 19.10  19.32  17.91  18.81  229,750 
01/10/2025 20.85  20.85  19.27  19.58  190,600 
01/08/2025 21.63  22.23  20.65  21.49  165,671 
01/07/2025 22.59  23.62  21.44  21.86  202,952 
01/06/2025 23.31  24.00  22.90  23.12  218,471 
01/03/2025 22.91  23.80  22.64  23.23  193,336 
01/02/2025 23.49  23.84  22.44  22.89  277,990 
12/31/2024 22.60  23.37  21.33  22.86  349,429 
12/30/2024 22.19  22.54  21.29  22.28  253,689 
12/27/2024 24.83  24.83  22.96  22.97  158,662 
12/26/2024 23.32  24.84  23.01  24.10  217,217 
12/24/2024 22.27  22.85  22.03  22.62  76,117 
12/23/2024 22.65  22.92  21.99  22.50  184,450 
12/20/2024 21.78  23.89  21.51  22.64  466,317 
12/19/2024 22.02  23.20  21.34  22.08  299,837 
12/18/2024 23.97  24.02  21.68  21.79  303,613 
12/17/2024 24.74  25.35  22.92  23.72  296,478 
12/16/2024 23.36  25.18  22.97  25.13  280,445 

About Neurogene Stock history

Neurogene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurogene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurogene stock prices may prove useful in developing a viable investing in Neurogene
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.7 M14 M

Neurogene Quarterly Net Working Capital

127.85 Million

Neurogene Stock Technical Analysis

Neurogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neurogene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurogene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Neurogene Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neurogene's price direction in advance. Along with the technical and fundamental analysis of Neurogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Neurogene Stock analysis

When running Neurogene's price analysis, check to measure Neurogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurogene is operating at the current time. Most of Neurogene's value examination focuses on studying past and present price action to predict the probability of Neurogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurogene's price. Additionally, you may evaluate how the addition of Neurogene to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk